In clinical trials, tirzepatide demonstrated dose-dependent weight reduction, with participants in the SURMOUNT-1 trial achieving average weight loss of 15% to 20.9% of body weight over 72 weeks, depending on the dose (5 mg, 10 mg, or 15 mg weekly)
Hansoh Pharma has been ranked among the top 100 global pharmaceutical companies and the top 3 best industrial enterprises in China in terms of pharmaceutical R&D pipeline for several years and is a national key high-tech enterprise and a national technology innovation demonstration enterprise
The NAD+ program supports cellular energy, sharpens your mind, and helps you age vibrantly
Each weight loss journey is unique, and for some, the weight lost with semaglutide can be life-changing when guided by the right professionals and regular follow-ups
It plays a crucial role in blood sugar regulation and appetite control